InmeRsiVa: Biomarkers in Dementia and Mental Health using XR and EdgeAI is a project led by INSATI in collaboration with the Singapore University of Social Sciences (SUSS) and LEX GLOBALMINDS, funded under the 2024 Eureka Innowwide call. SUSS is Singapore’s leading university in the fields of social sciences and gerontological studies, with a team of professionals trained in healthcare, social services, and psychology. LEX GLOBALMINDS is a consultancy based in Singapore with a presence in the EU and UK, providing support services for innovation projects with a focus on the healthcare and care sectors.
Eureka Innowide is a call for innovative companies like INSATI, focused on assessing the feasibility of research projects or commercial ambitions in international markets for 6 months, in collaboration with local partners. The proposal has reached 8th place out of 624 proposals submitted, obtaining the highest score in Spain and Singapore.
The main goal of the project is the technological validation of inmeRsiVa through a proof of concept in Singapore’s emerging health and care sector, which is facing increasing demands for innovative and accessible solutions for dementia and mental health care. This pilot will assess the technical, commercial, and regulatory feasibility of a set of emerging technologies that INSATI has been working on intensively in recent years.
The project’s approach integrates Extended Reality (XR), Artificial Intelligence (AI), Edge Computing, and IoT to offer a physical-cognitive stimulation activity program that, through immersive experiences, enhances users’ cognitive and motor skills. The aim is to contribute to an improvement in their overall well-being by analyzing high-value clinical data in a non-invasive, ethical, and safe manner. These activities are specifically designed to adapt to each user’s individual needs, promoting interaction and active participation throughout the process.
The proposal is based on INSATI’s extensive experience in R&D projects, clinical trials and Living Labs in the field of neurodegenerative diseases and mental health. INSATI collaborates closely under an open innovation model with healthcare services, biomedical research institutes, technology centers, research groups, and user associations.
The ultimate and disruptive objective of this line of research is the identification of new digital biomarkers that facilitate the early detection of certain neurodegenerative diseases, paving the way toward Predictive, Preventive, Personalized, and Participatory medicine.
